News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Cockroft Bettina M.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/12/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 08/10/2023 |
4/A
| Cockroft Bettina M. (Director) has filed a Form 4 on CNS Pharmaceuticals, Inc.|
Txns:
| Granted 2,099 options to buy
@ $1.67, valued at
$3.5k
|
|
| 06/12/2023 |
4
| Cockroft Bettina M. (Director) has filed a Form 4 on Annexon, Inc.|
Txns:
| Granted 24,000 options to buy
@ $2.88, valued at
$69.1k
|
|
| 05/09/2023 |
4
| Cockroft Bettina M. (Director) has filed a Form 4 on CNS Pharmaceuticals, Inc.|
Txns:
| Granted 8,300 options to buy
@ $1.67, valued at
$13.9k
|
|
| 05/09/2023 |
3
| Cockroft Bettina M. (Director) has filed a Form 3 on CNS Pharmaceuticals, Inc. |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2022 |
4
| Cockroft Bettina M. (Director) has filed a Form 4 on Annexon, Inc.|
Txns:
| Granted 20,000 options to buy
@ $8.08, valued at
$161.6k
|
|
| 01/20/2022 |
3
| Cockroft Bettina M. (Director) has filed a Form 3 on Annexon, Inc. |
|
|